Company · CIK 0001997038
Iambic Therapeutics, Inc.
IAMSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$16.01−$0.33 (−2.02%)
IAM · Last trade
- Prev close
- $16.34
- Range (5d)
- $16.01 – $23.81
On the record
Recent filings
- 8-KIAMCurrent report0001193125-26-424242 · 435.4 KBSEC(opens sec.gov)
- S-1/AIAMIambic Therapeutics, Inc.0001193125-26-417416 · 48.6 MBSEC(opens sec.gov)
- S-1IAMIPO registration0001193125-26-396704 · 57.2 MBSEC(opens sec.gov)
Insiders
- Catalio Capital Management, LP10% Owner
- EMSTER KURT VONDirector
- Hirawat SamitDirector
- Josephson NeilChief Medical Officer
- Miller Thomas F.Director, Chief Executive Officer
- Petrocheilos George C10% Owner
- RASTETTER WILLIAM HDirector, Chairperson of the Board
- Secora MichaelCFO & Chief Corp Dev Ofcr
- Sharp ShaliniDirector
- TAGLIAFERRI MARYDirector
Tickers
Addresses
business
5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO, CA, 92121
mailing
5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO, CA, 92121
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies